Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/TENAYA-THERAPEUTICS-INC-125290483/attualita/Tenaya-Therapeutics-Inc-Somministra-il-primo-paziente-nello-studio-clinico-di-fase-1b-MyPeak-1-St-44993053/?utm_source=whatsapp&utm_medium=social&utm_campaign=share